Maroun Dick
Neurology · Germantown, TNNPI 1942273826
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 426 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,869 and has fallen 99.3% since, to $19 in 2024.
Across 426 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SK Life Science, Inc.$1K
- Eisai Inc.$1K
- AbbVie$911
- Sunovion Pharmaceuticals Inc.$538
- Amgen$510
- Teva Pharmaceuticals USA, Inc.$453
- plus $3K from 20 others
What the payments were for
- Food & beverage$7,84799%
- Education$911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SK Life Science, Inc. | 51 | $1,115 |
| Eisai Inc. | 49 | $1,050 |
| AbbVie(2 entities) | 52 | $911 |
| Sunovion Pharmaceuticals Inc. | 33 | $538 |
| Amgen | 22 | $510 |
| Teva Pharmaceuticals USA, Inc. | 20 | $453 |
| UCB, Inc. | 20 | $438 |
| Lilly USA, LLC | 17 | $389 |
| Supernus Pharmaceuticals, Inc. | 23 | $348 |
| Biohaven Pharmaceuticals, Inc. | 33 | $346 |
| Biohaven Pharmaceutical Holding Company Ltd. | 28 | $334 |
| Novartis | 18 | $330 |
| Jazz Pharmaceuticals Inc. | 11 | $250 |
| Amneal Pharmaceuticals LLC | 10 | $177 |
| Upsher-smith Laboratories LLC | 7 | $161 |
| Vanda Pharmaceuticals Inc. | 8 | $151 |
| AstraZeneca | 7 | $134 |
| Harmony Biosciences LLC | 5 | $89 |
| Boston Scientific | 2 | $37 |
| Lundbeck LLC | 2 | $36 |
| Biogen | 2 | $35 |
| Neurelis, Inc. | 2 | $30 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Nevro Corp. | 1 | $17 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,938 in reported general payments places this provider in the 65th percentile of 361 neurology providers in Tennessee.
Other neurology in Germantown
- Shiva NatarajanGermantown$139K
- Rance WilbournGermantown$52K
- Samuel HunterSpring Hill$676K
- Harold MosesNashville$438K
- Lucas ElijovichMemphis$415K
- David BrandesKnoxville$412K
- Sibyl WrayKnoxville$377K
- Christine HagenAlcoa$371K
- Mark LedouxMemphis$352K
- Christopher PendolaKingsport$344K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.